Pharmaceutical & Drug Manufacturers Pharmaceutical & Drug Manufacturers Pharmaceutical & Drug Manufacturers
BUSINESS DIRECTORY PRODUCT CATALOG PHARMACEUTICAL CATALOGS PHARMA TRADE LEADS EXPORT IMPORT POLICIES POLICIES & ORDERS

Home » Pharmaceutical Drugs » Pharmaceutical Finished Formulations » Tablets »

Finished Formulations
Pharmaceutical Drugs

Glossary



SERRATIOPEPTIADASE


Serratiopeptidase is an enzyme having anti-inflammatory, anti-oedemic and fibrinolytic activity and it also acts rapidly on localized inflammation The drug improves aggravated circulation in the inflammatory focus by breaking down abnormal exudates and protein by promoting the absorption of the decomposed products through the blood and lymphatic vessels.

It also accelerates the elimination of sputum, pus and haematoma by breaking down the liquefying mucus secretions and fibrin clots. Another major useful action being increased concentration of antibiotics in the focus of infection.

Dosage
5-10 mg thrice a day after meals

Contra- Indications: Blood coagulation abnormalities

Side Effects
The drug has certain side effects, that can affect individuals in different ways. The following are some of the side effects, that are often associated with the drug:
  • Anorexia
  • Gastric Discomfort
  • Nausea
Discontinue use of hypersensitive symptoms such as eruptions appear. The drug should be used wit caution by pregnant and lactating women.

Disclaimer: The above information is for general understanding of the visitor. Please consult a registered medical practitioner before taking the aforesaid medicine.